EICHORCondition: Dyspnea; Cardiac · Sponsor: Ziekenhuis Oost-Limburg
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
CPETecho is progressively employed in diagnostic settings for pathophysiological detection, offering comprehensive assessment of both pulmonary and cardiac functions. This technique evolves from its invasive counterpart, where a diagnostic catheter is employed for hemodynamic monitoring, by substituting the invasive component with non-invasive echocardiography. Nevertheless, data on the test-retest reliability of CPETecho remain sparse, a factor critical in differentiating between measurement effects and actual therapeutic impacts.
This description comes directly from the study's public registry record.
Philippe Bertrand, MD, PhD · 0032471626094 · philippe.bertrand@zol.be
Sebastiaan Dhont, MD · 0032471626094 · sebastiaan.dhont@zol.be
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Capable of performing a maximal exercise test. * Provide signed and dated informed consent. Exclusion Criteria: \- Unstable symptoms, whereby therapy cannot be delayed for a week.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Ziekenhuis Oost-Limburg | Genk, Belgium | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07281534